Radiofrequency ablation methods for uterine sparing fibroid treatment.
| Autor: | Baxter BL; Department Obstetrics & Gynecology, Division of Gynecologic Specialty Surgery, Department of Obstetrics & Gynecology, Columbia University Irving Medical Center, New York, New York, USA., Seaman SJ, Arora C, Kim JH |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current opinion in obstetrics & gynecology [Curr Opin Obstet Gynecol] 2022 Aug 01; Vol. 34 (4), pp. 262-269. |
| DOI: | 10.1097/GCO.0000000000000801 |
| Abstrakt: | Purpose of Review: This article provides a clinical review of radiofrequency ablation (RFA) for the treatment of uterine leiomyomas. Recent Findings: RFA is an effective and durable treatment for fibroids with sustained improvements in fibroid volume, bleeding, and patient reported outcomes with low reintervention rates. Although fertility data is limited, it is overall positive and may represent a uterine conserving and fertility preserving treatment modality. Summary: RFA is a safe and effective uterine preserving treatment option for symptomatic leiomyomas. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|